Table 1.
CCR | CXCR | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 1 | 2 | 3 | 4 | 5 | 6 | |
Keratinocytes | – | – | + | + | – | + | – | – | + | – | + | – | + | – | – | – |
Fibroblasts | – | – | + | + | – | – | – | – | – | + | – | – | – | – | – | – |
Endothelial cells | – | – | + | + | – | + | – | + | + | + | + | + | + | – | – | – |
Flow cytometry was performed with PE-labeled anti-chemokine receptor mAbs directed against CCR1 to CCR10 and CXCR1 to CXCR6 or specific isotype controls using cultured primary cells. Representative results of three different donors